From: Biomarkers of lipid metabolism in gastric cancer: a case control study
Total | Male | Female | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
GC* | Control | t/ x2 | P | GC | Control | t/ x2 | P | GC | Control | t/ x2 | P | |
TG(mmol/L)# | 1.409 ± 0.933 | 1.329 ± 1.055 | 1.902 | 0.047 | 1.367 ± 0.894 | 1.373 ± 1.085 | 0.116 | 0.907 | 1.522 ± 0.059 | 1.214 ± 0.055 | 3.836 | < 0.001 |
TC(mmol/L) # | 4.945 ± 1.177 | 4.862 ± 1.021 | 1.755 | 0.076 | 4.825 ± 1.026 | 4.782 ± 0.998 | 0.851 | 0.395 | 5.268 ± 1.467 | 5.072 ± 1.052 | 1.897 | 0.058 |
HDL(mmol/L) # | 1.332 ± 0.687 | 1.423 ± 0.354 | 3.959 | < 0.001 | 1.267 ± 0.706 | 1.349 ± 0.337 | 2.991 | 0.003 | 1.508 ± 0.598 | 1.620 ± 0.319 | 2.876 | 0.004 |
LDL(mmol/L) # | 3.045 ± 1.034 | 2.812 ± 0.854 | 5.836 | < 0.001 | 2.997 ± 1.052 | 2.768 ± 0.835 | 4.884 | < 0.001 | 3.177 ± 0.974 | 2.930 ± 0.891 | 3.381 | 0.001 |
TG(n,%)& | 225(20.1%) | 265(23.4%) | 3.562 | 0.066 | 149(18.2%) | 206(25.1%) | 11.328 | 0.001 | 76(25.2%) | 59(18.9%) | 3.501 | 0.065 |
TC(n,%)& | 417(37.2%) | 407(35.9%) | 0.437 | 0.512 | 272(33.3%) | 269(32.7%) | 0.051 | 0.834 | 145(48.0%) | 138(44.2%) | 0.884 | 0.373 |
HDL(n,%)& | 179(16.0%) | 129(11.4%) | 10.135 | 0.002 | 138(16.9%) | 105(12.8%) | 5.452 | 0.022 | 41(13.6%) | 24(7.7%) | 5.613 | 0.019 |
LDL(n,%)& | 452(40.4%) | 384(33.9%) | 10.186 | 0.001 | 311(38.0%) | 254(30.9%) | 9.202 | 0.003 | 141(46.7%) | 130(41.7%) | 1.570 | 0.223 |